LDE225 in Combination With Paclitaxel in Patients With Advanced Solid Tumors - A Multicenter Phase I Trial

Trial Profile

LDE225 in Combination With Paclitaxel in Patients With Advanced Solid Tumors - A Multicenter Phase I Trial

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2017

At a glance

  • Drugs Sonidegib (Primary) ; Paclitaxel
  • Indications Anal cancer; Breast cancer; Cholangiocarcinoma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Solid tumours; Uterine cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Mar 2017 Results assessing safety and efficacy of sonidegib in combination with paclitaxel, published in the Investigational New Drugs
    • 23 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 28 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top